Literature DB >> 24634937

Practice to minimize the use of blood products improve outcome after hepatic resection for hepatocellular carcinoma.

Hiroaki Shiba, Yuichi Ishida, Yuki Fujiwara, Shigeki Wakiyama, Takeshi Gocho, Ryusuke Ito, Taro Sakamoto, Nobuhiro Tsutsui, Tomonori lida, Michinori Matsumoto, Kenei Furukawa, Koichiro Haruki, Shoichi Hirohara, Takeyuki Misawa, Katsuhiko Yanaga.   

Abstract

BACKGROUND/AIMS: Because recent studies have reported that allogenic blood transfusion exerts negative immunomodulatory effects, we tried decreasing the use of blood products in perioperative management of hepatic resection since 2003. We retrospectively assessed the changes in our blood transfusion policy on hepatic resection for hepatocellular carcinoma (HCC).
METHODOLOGY: Subjects were 78 patients who underwent hepatic resection for HCC at Jikei University Hospital. Patients were classified into 2 groups; early period (2000-2002, n=25), and late period (2003-2006, n=53). Perioperative findings including age, gender, hepatitis virus, preoperative ICGR15, Child's classification, tumor factor, type of resection, duration of operation, blood loss, the amount of peri-operative red cell concentration (RC) and fresh frozen plasma (FFP) transfusion, incidences of post-operative complication, as well as disease-free and overall survival were analyzed.
RESULTS: The amount of perioperative RC (p=0.041) and FFP (p<0.001) transfusion in late period were significantly smaller and non-anatomical limited partial resection (p=0.004) in late period was greater than early period. The patients in late period had significantly better overall survival rate than those in early period (p<0.001).
CONCLUSIONS: Practice to minimize the use of blood products may improve patient's survival after hepatic resection for HCC.

Entities:  

Mesh:

Year:  2013        PMID: 24634937

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Blood transfusion is an independent predictor of morbidity and mortality after hepatectomy.

Authors:  Allison N Martin; Matthew J Kerwin; Florence E Turrentine; Todd W Bauer; Reid B Adams; George J Stukenborg; Victor M Zaydfudim
Journal:  J Surg Res       Date:  2016-07-15       Impact factor: 2.192

Review 2.  Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.

Authors:  René Fahrner; Felix Dondorf; Michael Ardelt; Yves Dittmar; Utz Settmacher; Falk Rauchfuß
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  Impact of operative and peri-operative factors on the long-term prognosis of primary liver cancer patients undergoing hepatectomy.

Authors:  Li-Ning Xu; Ying-Ying Xu; De-Wei Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

4.  Variable Pringle Maneuvers and Effect on Intestinal Epithelium in Rats. A Pilot Experimental Study in Rats.

Authors:  Dimitrios Dimitroulis; Demetrios Moris; Emmanouil Pikoulis; Eleftherios Spartalis; Georgios Kontadakis; Bart Vrugt; Serena Valsami; Gregory Kouraklis
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

5.  Association between gastric Candida colonization and surgical site infections after high-level hepatobiliary pancreatic surgeries: the results of prospective observational study.

Authors:  Kazuyuki Gyoten; Hiroyuki Kato; Aoi Hayasaki; Takehiro Fujii; Yusuke Iizawa; Yasuhiro Murata; Akihiro Tanemura; Naohisa Kuriyama; Masashi Kishiwada; Shugo Mizuno; Masanobu Usui; Hiroyuki Sakurai; Shuji Isaji
Journal:  Langenbecks Arch Surg       Date:  2020-10-15       Impact factor: 3.445

6.  Extracellular ubiquitin inhibits the apoptosis of hepatoma cells via the involvement of macrophages.

Authors:  Jiajing Cai; Xuemeng Qian; Qi Qi; Jia Han; Xinfang Zhu; Qi Zhang; Rong Xia
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.